1. $NVS: New SEC Filing for NVS: Form SD, No. 0001104659-16-124277 http://stocknewsflow.com/1114448_000110465916124277_0001104659-16-124277

  2. <br/> http://www.conferencecalltranscripts.org/no/summary2/?id=2811197 $NVS

  3. Pharma Giant Novartis Is a Great Bargain for Investors $NVS https://www.thestreet.com/story/13588581/1/pharma-giant-novartis-is-a-great-bargain-for-investors.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  4. $NVS Needs to retest 79.90 and hold for confirmation. *Watching closely

  5. $NVS $ABT $MRK $ABBV these till 2028

  6. Elefante Mark B appears to have added to its $NVS position in the most recent quarter http://www.conferencecalltranscripts.org/summaryh/?id=2802250

  7. Vaccine Makers Are Down to Four Drug Companies. $NVS $GSK $PFE $MRK #SNY http://www.wyattresearch.com/article/vaccines-down-to-four-pharmaceutical-companies/

  8. $nvs puts way too fast and too many gaps

  9. Novartis AG s buy rating reiterated at JPMorgan Chase & Co.. http://www.marketbeat.com/r/652096 $NVS

  10. $NVS $$$

  11. $NVS Novartis AG Correlation Histogram MODE : 0.9 #bigdata http://dataunion.tistory.com/922

  12. Novartis CEO Says Company Open To Selling Its $14 Billion Stake In Roche If The... $NVS $RHHBY http://www.benzinga.com/news/16/05/8028873/novartis-ceo-says-company-open-to-selling-its-14-billion-stake-in-roche-if-the-op

  13. $NVS (+1.1% pre) Novartis willing to sell Roche stake without demanding premium : CEO - Reuters http://www.reuters.com/article/us-novartis-heart-drug-idUSKCN0YG13G

  14. Mix Wondering Stocks- $XCO $EBAY $NVS http://www.senecaglobe.com/mix-wondering-stocks-exco-resources-nysexco-ebay-nasdaqebay-novartis-nysenvs/325620/

  15. The seasonality trend for $NVS might surprise traders this year. http://financhill.com/search/seasonality/NVS?_source=stocktwits

  16. 27.5% earnings growth next year? Check out Novartis $NVS https://simplywall.st/NYSE:NVS/?utm_source=trending&utm_medium=stocktwits&utm_content=positive&utm_campaign=eps_growth&anchor=growth-in-earnings#growth-in-earnings

  17. $NVS Meet Novartis Management investor event- Sandoz Presentation is now available https://app.scoutfin.com/document.html?id=5744dfaef99d16b714a64ca8&_branch_match_id=link-263793519662086405

  18. $NVS Meet Novartis Management investor event- R&D and Oncology Presentation is now available https://app.scoutfin.com/document.html?id=5744df4f46ee74cd05d35173&_branch_match_id=link-263793119500318128

  19. $NVS Meet Novartis Management investor event- Pharmaceuticals Presentation is now available https://app.scoutfin.com/document.html?id=5744ded2f99d16b714a64ca5&_branch_match_id=link-263792598366435816

  20. $NVS Meet Novartis Management investor event- Novartis Group Presentation is now available https://app.scoutfin.com/document.html?id=5744dea146ee74cd05d35171&_branch_match_id=link-263792392321251382

  21. $NVS Meet Novartis Management investor event- NIBR Presentation is now available https://app.scoutfin.com/document.html?id=5744de75f99d16b714a64ca3&_branch_match_id=link-263792205943159705

  22. $NVS Meet Novartis Management investor event- Alcon Presentation is now available https://app.scoutfin.com/document.html?id=5744de4df99d16b714a64ca1&_branch_match_id=link-263792037910951023

  23. $NVS constructive weekly chart .Above 30wMA . Seems eur.Big Pharma are value plays for Big Funds needing divvy plays

  24. MACD Bull Crossover: $ADM, $BBY, $FEYE, $HPE, $MAT, $MESG, $NVS http://www.ninestocks.com/2016/05/macd-bull-crossover-archer-daniels-midland-company-adm-best-buy-co-bby-fireeye-inc-feye-hewlett-packard-enterprise-comp-hpe-mattel-inc-mat-xura-inc-cmn-stk-mesg-novartis-ag-nvs/

  25. Novartis AG s neutral rating reiterated at Citigroup Inc.. http://www.marketbeat.com/r/650804 $NVS